Decreased hepatic glucagon responses in Type 1 (insulin-dependent) diabetes mellitus
✍ Scribed by L. Ørskov; K. G. M. M. Alberti; A. Mengel; N. Møller; O. Pedersen; O. Rasmussen; T. Seefeldt; O. Schmitz
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 673 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
✦ Synopsis
The effect of glucagon infusion on hepatic glucose production during euglycaemia was evaluated in seven Type i (insulin-dependent) diabetic patients and in ten control subjects. In the diabetic subjects normoglycaemia was maintained during the night preceding the study by a variable intravenous insulin and glucose infusion. During the study endogenous insulin secretion was suppressed by somatostatin (450gg/h) and replaced by insulin infusion (0.15 mU. kg -1. min-9. 3H-glucose was infused for isotopic determination of glucose turnover. Plasma glucose was damped at 5 mmol/1 for 2 h 30 min and glucagon (1.5 ng. kg -1. min-0 was then infused for the following 3 h. Hepatic glucose production and glucose utilisation were measured during the first, second and third hour of the glucagon infusion. Basal hepatic glucose production (just prior to glucagon infusion) was similar in diabetic (1.2 +0.3 rag. kg -1. min -1) and control (1.6 _+ 0.1 mg-kg -1. min-0 subjects. In diabetic
📜 SIMILAR VOLUMES
Hepatic glucose production (3H-glucose technique) and insulin-mediated glucose uptake (insulin clamp technique) were measured in 38 Type 2 (non-insulin-dependent) and 11 Type 1 (insulin-dependent) diabetic patients. Fasting plasma glucose concentration was 8.3 4-0.5 mmol/1 in the former, and 9.6 + 1
Kidney haemodynamics appear to change after the early phases of diabetic nephropathy: increases in glomerular filtration rate and in renal plasma flow have been widely reported, while kidney size is increased. As the renal kallikrein-kinin system has been demonstrated to regulate kidney blood circul
Hepatic and peripheral insulin sensitivity were investigated in five newly diagnosed Type 1 (insulin-dependent) diabetic subjects before and after 1 week of twice daily insulin therapy. Eight weight-matched control subjects were also studied. Hepatic glucose production and glucose utilization were m
Glucagon may play a role in the metabolic derangements of overt Type 2 (non-insulin-dependent) diabetes mellitus. We therefore have evaluated the early steps in glucagon action by investigating the hormone-sensitive adenylyl cyclase system in liver membranes from seven Type 2 diabetic patients with